Oracle Investor Day to Focus on OCI Capacity Ramp, Applications Growth, RBC Says
MT newswire2026/10/22 14:49Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
10:49 AM EDT, 10/22/2026 (MT Newswires) -- Oracle's (ORCL) investor day is expected to provide further visibility on Oracle Cloud Infrastructure's capacity ramp and margin trajectory, along with clearer performance expectations for the applications business, RBC Capital Markets said. Investors will look for timelines for AI infrastructure gross margins to stabilize within the guided 30% to 40% range, with execution risks underscored by the recent Project Jupiter Force Majeure notice, the investment firm said in a research note Wednesday. RBC will look for a clear path to sustained double-digit SaaS growth via embedded AI and agentic applications. Key investor questions include whether agentic AI tooling is compressing deployment timelines and expanding the on-premises migration funnel, as well as the monetization pathway for Fusion Agentic Applications and the AI Agent Studio. The brokerage is also watching for updates to Oracle's long-term financial targets, including its fiscal 2030 revenue target of $225 billion and earnings per share target of $21, as well as a clearer path toward improved free cash flow conversion amid elevated capital expenditures. RBC maintained its sector perform rating and $165 price target. Oracle's shares were down 1.4% in early Thursday trading. Price: 127.38, Change: -1.75, Percent Change: -1.36
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Mid-point pricing, oversubscribed issuance: Bambusa (BBTX.US) IPO raises 169 million USD, market cap set at 815 million USD
Biotechnology company Bambusa priced its expanded IPO at a midpoint of $16, raising $168.9 millions, with a valuation of $815 millions. It will be listed on NASDAQ this Friday.
智通财经•2026/10/30 02:53

Cramer Calls Microsoft a Buy, Says Alphabet Carries Too Much Baggage
BeInCrypto•2026/10/30 02:21

New York gold prices fell on the 29th
新浪财经•2026/10/30 02:13
Crypto prices
MoreBitcoin
BTC
$77,383.99
-2.87%
Ethereum
ETH
$2,210.97
-3.78%
Tether USDt
USDT
$0.9990
+0.03%
BNB
BNB
$714.06
-4.08%
XRP
XRP
$1.22
-5.08%
USDC
USDC
$1
+0.15%
Solana
SOL
$95.32
-4.16%
TRON
TRX
$0.3559
+7.92%
Hyperliquid
HYPE
$91.45
+16.93%
Zcash
ZEC
$1,264.8
+2.09%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now